Neuropsychiatric adverse effects attributed to use of oxybutynin;Neuropsychiatrische bijwerkingen toegeschreven aan het gebruik van oxybutynine

Nederlands Tijdschrift voor Geneeskunde

Volumn 142, Issue 11, 1998, Pages 590-592

  In 'T Veld, B A ^a,b   Kwee Zuiderwijk, W J M ^a,c   Van Puijenbroek, E P ^a,c   Stricker, B H Ch ^a,b  

^a Sectie Geneesmiddelenbewaking   (Netherlands)

^b ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^c Stichting Landelijke Registratie E

Author keywords

[No Author keywords available]

Indexed keywords

OXYBUTYNIN;

ADULT; AGITATION; APATHY; ARTICLE; CHILD; CLINICAL ARTICLE; CONCENTRATION LOSS; DOSE RESPONSE; DROWSINESS; DRUG WITHDRAWAL; FEMALE; HALLUCINATION; HUMAN; MALE; NEUROPSYCHIATRY; PSYCHOSIS; SOMNOLENCE;

AGED; AGED, 80 AND OVER; CHILD; ENURESIS; FEMALE; HUMANS; MALE; MANDELIC ACIDS; MENTAL DISORDERS; PARASYMPATHOLYTICS; URINARY INCONTINENCE;

EID: 0032515816     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Dollery C. Therapeutic drugs. New York: Churchill & Livingstone, 1992 Suppl:152-6.
2. Jonville AP, Duiertre JP, Autret E, Barbellion M. Effets indésirables du chlorure d'oxybutynine (Ditropan). Bilan de l'enquête officielle des Centres Régionaux de Pharmacovigilance. Therapie 1992;47:389-92.
3. Repertorium 1996/97. Utrecht: Nefarma, 1996:475.
4. Ziekenfondsraad. In: Kuy A van der, redacteur. Farmacotherapeutisch kompas. Amstelveen: Centrale Medisch Pharmaceutische Commissie, 1997:478.
5. Stricker BHCh. Bijwerkingen van geneesmiddelen: de causaliteitsbeoordeling. Ned Tijdschr Geneeskd 1989;133:275-80.
6. Lish PM, Labudde JA, Peters EL, Robbins SI. Oxybutynin - a musculotropic antispasmodic drug with moderate anticholinergic action. Arch Int Pharmacodyn 1965;156:467-88.
7. Nilvebrant L, Sparf B. Dicyclomine, benzhexol and oxybutynine distinguish between subclasses of muscarinic binding sites. Eur J Pharmacol 1986;123:133-43.
8. Anderson GF, Fredericks CM. Characterization of the oxybutynin antagonism of drug-induced spasms in detrusor. Pharmacology 1977;15:31-9.
9. Fredericks CM, Anderson GF, Kreulen DL. A study of the anticholinergic and antispasmodic activity of oxybutynin (Ditropan) on rabbit detrusor. Invest Urol 1975;12:317-9.
10. Autret E, Jonville AP, Dutertre JP, Bertiere MC, Robert M, Averous M, et al. Plasma levels of oxybutynine chloride in children. Eur J Clin Pharmacol 1994;46:83-5.